Your fact-checks will appear here
The Federal Trade Commission's efforts to target online sellers of purported diabetes treatments from 2021 to 2025, including consumer warnings, cease-and-desist letters, and enforcement settlements.
In the last five years the Federal Trade Commission has repeatedly targeted online sellers of purported diabetes treatments—issuing public consumer warnings, coordinating with the FDA to send cease-an...
Federal regulators have a track record of acting against sellers of fraudulent diabetes cures—most notably a coordinated FTC/FDA sweep in 2006 that produced warning letters and referrals to foreign au...
Since 2018 the Federal Trade Commission has continued a multi-pronged enforcement and policy campaign against companies that use fake celebrity endorsements to sell supplements—bringing lawsuits and c...